Pharmaceutical Product Development (PPDI) NewsBite - PPDI Lower on Downgrade

Pharmaceutical Product Development Inc. (PPDI) opened at 45.17. So far today, the stock has hit a low of 44.66 and a high of 47.11.

PPDI is now trading at 46.22, down 0.64 (-1.42%). The stock hit its 52 week high of 47.11 today and set its 52 week low of 30.52 in March. PPDI has been climbing for the past year. Shares of Pharmaceutical Product Development have been trading lower today after a Robert W. Baird analyst downgraded the stock to "Neutral" from "Outperform" saying its 2008 development guidance appears full and margins look full. Technical indicators for the stock are bullish and steady while S&P gives PPDI a positive 4 STARS (out of 5) buy rating.

If you’re looking for a hedged play on this stock, consider an April bull-put credit spread below the $37.50 range. PPDI stock could fall up to 18.9% before expiration and this position would still be profitable. [RHF - Seven Summits Strategic Investments NewsBite]

Source :

0 التعليقات:

  ©Template by Dicas Blogger.